Other Local Peers |
EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), CORTEXYME INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), DERMIRA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AGENUS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NANTKWEST INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), EQUILLIUM INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VACCINEX INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SAVARA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SOLIGENIX INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), TOCAGEN INC (NASDAQ), OCUGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TROVAGENE INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ) |
Other Global Peers |
HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), POLYNOVO LIMITED (ASX), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), BBI LIFE SCI (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), UNI-BIO GROUP (HKEx), NANOVIRICIDES INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), IBIO INC (NYSE American), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), EXTRAWELL PHAR (HKEx), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ANTEOTECH LIMITED (ASX), CELLMID LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), CCP TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), MEGASUN (Bursa), HAO WEN HLDGS (HKEx), MGRC (Bursa), SIENNA CANCER DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX) |